Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic.
cancer
chemotherapy
coronavirus disease 2019 (COVID-19)
pandemic
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
25
05
2020
accepted:
20
07
2020
entrez:
28
9
2020
pubmed:
29
9
2020
medline:
29
9
2020
Statut:
epublish
Résumé
On March 11, 2020, the WHO has declared the coronavirus disease 2019 (COVID-19) a global pandemic. As the last few months have profoundly changed the delivery of health care in the world, we should recognize the effort of numerous comprehensive cancer centers to share experiences and knowledge to develop best practices to care for oncological patients during the COVID-19 pandemic. Patients as well as physicians must be aware of all these constraints and profound social, personal, and medical challenges posed by the tackling of this deadly disease in everyday life in order to adjust to such a completely novel scenario. This review will discuss facing the challenges and the current approaches that cancer centers in Italy and United States are adopting in order to cope with clinical and research activities.
Identifiants
pubmed: 32984015
doi: 10.3389/fonc.2020.01556
pmc: PMC7489342
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1556Informations de copyright
Copyright © 2020 Terracciano, Buonerba, Scafuri, De Berardinis, Calin, Ferrajoli, Fabbri and Cimmino.
Références
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
J Med Virol. 2020 Apr 24;:
pubmed: 32330291
Cent European J Urol. 2020;73(1):26-32
pubmed: 32395319
Clin Chem Lab Med. 2020 Jun 25;58(7):1156-1159
pubmed: 32301750
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Cancer Discov. 2020 Aug;10(8):1121-1128
pubmed: 32398243
Clin Chem Lab Med. 2020 Jun 25;58(7):1081-1088
pubmed: 32301749
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32303564
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Emerg Microbes Infect. 2020 Dec;9(1):747-756
pubmed: 32196430
Lancet Oncol. 2020 Apr;21(4):e181
pubmed: 32142621
Crit Rev Oncol Hematol. 2020 Jul;151:102992
pubmed: 32474391
Blood. 2020 May 21;135(21):1912-1915
pubmed: 32302379
Cancers (Basel). 2020 Feb 10;12(2):
pubmed: 32050629
J Med Virol. 2020 Mar 30;:
pubmed: 32227490
Sci Immunol. 2020 Jun 5;5(48):
pubmed: 32503877